Cross-sectional, case-control and longitudinal associations between exposure to glucagon-like peptide-1 receptor agonists and the dispensing of antidepressants.

Osvaldo P AlmeidaZheng FongLydia M Hill AlmeidaFrank M Sanfilippo Amy Theresa Page Christopher Etherton Beer

Published in: Diabetes, obesity & metabolism (2024)

Individuals exposed to GLP-1 receptor agonists are at greater risk of being dispensed antidepressants. The possible impact of GLP-1 receptor agonists on the mood of consumers requires ongoing vigilance and further research.

Keyphrases

case control
cross sectional
major depressive disorder
bipolar disorder
physical activity